The Congress includes...
Network with key innovators in Cancer Immunotherapy. 2022 Attendees included: Senior Clinical Pharmacologist, Bristol-Myers Squibb; Director, Pfizer; and Director, Novartis.
Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, intra-tumoural therapies, oncolytic viruses, bispecific drugs and cancer vaccines
Advance your understanding of Biomarker development and the Tumour micro-environment, from spatial biology multi omic approaches to biomarker technologies like mass spectrometry, immunohistochemistry and Cytof
Examine the latest challenges and technological innovations in preclinical and clinical development with discussions on animal modelling techniques and screening strategies in preclinical development along with the challenges of clinical trial design
Unparalleled Networking Opportunities. The two-day conference offers dedicated networking opportunities such as roundtable and panel discussions, creating an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organized 1-2-1 meetings
Network with key innovators in Cancer Immunotherapy. 2022 Attendees included: Senior Clinical Pharmacologist, Bristol-Myers Squibb; Director, Pfizer; and Director, Novartis.
Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, intra-tumoural therapies, oncolytic viruses, bispecific drugs and cancer vaccines
Advance your understanding of Biomarker development and the Tumour micro-environment, from spatial biology multi omic approaches to biomarker technologies like mass spectrometry, immunohistochemistry and Cytof
Examine the latest challenges and technological innovations in preclinical and clinical development with discussions on animal modelling techniques and screening strategies in preclinical development along with the challenges of clinical trial design
Unparalleled Networking Opportunities. The two-day conference offers dedicated networking opportunities such as roundtable and panel discussions, creating an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organized 1-2-1 meetings
